IH vs SLSN
Valuation
Profitability
Growth
Financial Health
Dividends
AI Verdict
iHuman Inc. presents a classic deep-value paradox: it possesses a stable Piotroski F-Score of 6/9 and an exceptionally clean balance sheet, yet it is plagued by severe growth decay. While the stock trades at a significant discount to its Graham Number ($4.08) and book value (P/B 0.61), the negative YoY revenue (-18.10%) and earnings (-33.30%) growth suggest a value trap. The current price of $1.74 is slightly below the growth-based intrinsic value of $1.82, but the bearish technical trend and weak insider sentiment offset the valuation appeal.
SLSN exhibits a stable Piotroski F-Score of 5/9, but this is overshadowed by severe valuation misalignment and negative growth. The stock is trading at $1.25, which is a massive premium compared to its Graham Number ($0.34) and Intrinsic Value ($0.14). With negative YoY revenue growth (-0.70%) and a catastrophic -50% decline in EPS growth, the current price is unsupported by fundamentals. The recent 1-month price bounce appears speculative given the 0/4 earnings beat record over the last year.
Compare Another Pair
Related Comparisons
IH vs SLSN: Head-to-Head Comparison
This page compares iHuman Inc. (IH) and Solesence, Inc. (SLSN) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.
Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.